Engineering exosomes and biomaterial-assisted exosomes as therapeutic carriers for bone regeneration

Stem Cell Res Ther. 2023 Mar 29;14(1):55. doi: 10.1186/s13287-023-03275-x.

Abstract

Mesenchymal stem cell-based therapy has become an effective therapeutic approach for bone regeneration. However, there are still limitations in successful clinical translation. Recently, the secretome of mesenchymal stem cells, especially exosome, plays a critical role in promoting bone repair and regeneration. Exosomes are nanosized, lipid bilayer-enclosed structures carrying proteins, lipids, RNAs, metabolites, growth factors, and cytokines and have attracted great attention for their potential application in bone regenerative medicine. In addition, preconditioning of parental cells and exosome engineering can enhance the regenerative potential of exosomes for treating bone defects. Moreover, with recent advancements in various biomaterials to enhance the therapeutic functions of exosomes, biomaterial-assisted exosomes have become a promising strategy for bone regeneration. This review discusses different insights regarding the roles of exosomes in bone regeneration and summarizes the applications of engineering exosomes and biomaterial-assisted exosomes as safe and versatile bone regeneration agent delivery platforms. The current hurdles of transitioning exosomes from bench to bedside are also discussed.

Keywords: Biomaterial-assisted exosomes; Bone regeneration; Exosome engineering; Exosomes; Mesenchymal stem cells; Preconditioning.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials / therapeutic use
  • Bone Regeneration / genetics
  • Exosomes* / genetics
  • Exosomes* / metabolism
  • Mesenchymal Stem Cells* / metabolism
  • Regenerative Medicine

Substances

  • Biocompatible Materials